Reply to "Letter to Dobesh et al. on lower mortality with andexanet alfa in factor Xa inhibitor-related major bleeding"

Res Pract Thromb Haemost. 2024 Apr 27;8(4):102429. doi: 10.1016/j.rpth.2024.102429. eCollection 2024 May.
No abstract available